COMMONWEALTH EQUITY SERVICES, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2022$13,000
-45.8%
10,129
-8.0%
0.00%
Q2 2022$24,000
-29.4%
11,014
+0.4%
0.00%
Q1 2022$34,000
-32.0%
10,969
-8.8%
0.00%
Q4 2021$50,000
-63.0%
12,023
-27.8%
0.00%
Q3 2021$135,000
-4.9%
16,659
-12.0%
0.00%
Q2 2021$142,000
-4.7%
18,923
+10.1%
0.00%
Q1 2021$149,000
+9.6%
17,1850.0%0.00%
Q4 2020$136,000
-0.7%
17,1850.0%0.00%
Q3 2020$137,000
-12.2%
17,185
+8.9%
0.00%
-100.0%
Q2 2020$156,000
+26.8%
15,785
-1.3%
0.00%0.0%
Q1 2020$123,000
+101.6%
15,9850.0%0.00%
Q4 2019$61,000
-23.8%
15,9850.0%0.00%
Q3 2019$80,000
-32.2%
15,985
-11.1%
0.00%
-100.0%
Q2 2019$118,000
-11.3%
17,985
+1.7%
0.00%0.0%
Q1 2019$133,000
-10.1%
17,685
-4.1%
0.00%0.0%
Q4 2018$148,000
-38.3%
18,435
-1.1%
0.00%0.0%
Q3 2018$240,000
+20.6%
18,635
+6.9%
0.00%0.0%
Q2 2018$199,00017,4350.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders